Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
CANOPY is a prospective, non-randomized, multicenter, single-arm post-approval study. The study is to demonstrate the long-term safety, efficacy and durability of the RX Acculink Carotid Stent System (Acculink Stent) with the RX Accunet Embolic Protection System in the treatment of atherosclerotic carotid artery disease subjects at standard risk for carotid endarterectomy. Subjects will be followed at 30 days and once a year for three years.
Sponsor: Abbott Vascular Solutions Inc., a subsidiary of Abbott Vascular Inc.
Principal investigators: Ethan Korngold, M.D., and Vivek Deshmukh, M.D.
Contact: Ellen Muir, CCRC, clinical research coordinator, 503-216-2110